Edge Capital Group, LLC Biogen Inc. Transaction History
Edge Capital Group, LLC
- $1.9 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
993Shares Held
131MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.43 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.37 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.12 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.07 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$765 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...